Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
ADCOCK INGRAM
Jun-14
SANOFI INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs7,939320-   
Low Rs5,454231-   
Sales per share (Unadj.) Rs1,202.895.3-  
Earnings per share (Unadj.) Rs269.5-24.0-  
Cash flow per share (Unadj.) Rs287.7-19.9-  
Dividends per share (Unadj.) Rs570.000-  
Avg Dividend yield %8.50-  
Book value per share (Unadj.) Rs527.074.8-  
Shares outstanding (eoy) m23.03168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.62.9 192.4%   
Avg P/E ratio x24.9-11.5 -216.4%  
P/CF ratio (eoy) x23.3-13.9 -168.0%  
Price / Book Value ratio x12.73.7 344.7%  
Dividend payout %211.50-   
Avg Mkt Cap Rs m154,22446,551 331.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m4,0592,922 138.9%   
Avg. sales/employee Rs Th03,747.7-  
Avg. wages/employee Rs Th0680.6-  
Avg. net profit/employee Rs Th0-944.3-  
INCOME DATA
Net Sales Rs m27,70116,089 172.2%  
Other income Rs m730113 647.9%   
Total revenues Rs m28,43116,201 175.5%   
Gross profit Rs m8,349-2,788 -299.5%  
Depreciation Rs m419694 60.3%   
Interest Rs m17436 3.9%   
Profit before tax Rs m8,643-3,806 -227.1%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,437238 1,024.8%   
Profit after tax Rs m6,206-4,054 -153.1%  
Gross profit margin %30.1-17.3 -173.9%  
Effective tax rate %28.2-6.2 -451.2%   
Net profit margin %22.4-25.2 -88.9%  
BALANCE SHEET DATA
Current assets Rs m36,12111,784 306.5%   
Current liabilities Rs m27,4256,630 413.7%   
Net working cap to sales %31.432.0 98.0%  
Current ratio x1.31.8 74.1%  
Inventory Days Days117111 105.2%  
Debtors Days Days17124 13.7%  
Net fixed assets Rs m12,1486,869 176.9%   
Share capital Rs m23075 307.9%   
"Free" reserves Rs m11,9060-   
Net worth Rs m12,13612,628 96.1%   
Long term debt Rs m04,438 0.0%   
Total assets Rs m48,27923,855 202.4%  
Interest coverage x509.4-7.7 -6,588.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 85.1%   
Return on assets %12.9-15.2 -85.0%  
Return on equity %51.1-32.1 -159.3%  
Return on capital %71.4-19.8 -360.2%  
Exports to sales %14.10-   
Imports to sales %14.60-   
Net fx Rs m-1330-   
CASH FLOW
From Operations Rs m3,9871,373 290.3%  
From Investments Rs m6,509-422 -1,543.6%  
From Financial Activity Rs m-15,8274,028 -393.0%  
Net Cashflow Rs m-5,3314,979 -107.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.42 Rs / ZAR

Compare SANOFI INDIA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: ADVANCED ENZYME TECHNOLOGIES  SUN PHARMA  PHAARMASIA  VALIANT LABORATORIES LTD.  BACIL PHARMA  



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.